Clinical Trial

Transcriptional and Epigenetic Program of PCOS Women

Study Description

Transcriptional and Epigenetic Program of PCOS Women

The main goal is to reveal differences in global gene expression in two different adipose tissue (AT) depots of females with and without polycystic ovary syndrome (PCOS) and how these are influenced by upstream epigenetic markers

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

DEXA

DEXA Scans will be performed to measure body fat and estimate muscle mass using a General Electric Lunar iDXA whole-body scanner.

Magnetic Resonance (MR) Assessment of the Abdomen

Include measures to assess liver lipid content and stiffness and perform volumetric fat quantitation.

MR assessment of Whole Body Fat

Volumetric measurement of fat, muscle and bone

Procedure - Adipose tissue biopsy

0.5 cm incision of the upper-outer right vastus lateralis, and either a 3-4mm Mercedes Liposuction needle, or a 4-6 mm Bergstrom needle will be inserted to aspirate approximately 7 grams of adipose tissue.

Oral glucose tolerance test

Glucose tolerance will be assessed with a 75 g oral glucose tolerance test (OGTT). Subjects will be studied after an overnight fast.

Additional Information

Official Study Title

Transcriptional and Epigenetic Program of PCOS Women

Clinical Trial ID

NCT04034706

ParticipAid ID

epYppa